Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Select Investment Series III SICAV - T. Rowe Price Health Sciences Equity Fund Qd Fonds 130137593 / LU2674532929

11.44 GBP
-0.06 GBP
-0.52 %
12.2.2025
NAV

Nettoinventarwert (NAV)

11.44 GBP -0.06 GBP -0.52 %
Vortag 11.50 GBP Datum 12.02.2025

Select Investment Series III SICAV - T. Rowe Price Health Sciences Equity Fund Qd Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 251.34%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Stellar ETP CH1109575535 159.23%
21Shares The Sandbox ETP CH1177361008 134.26%
21Shares Algorand ETP CH1146882316 94.49%
21Shares Sui Staking ETP CH1360612159 8.25%
21Shares Immutable ETP CH1360612142 -41.82%
21Shares Injective Staking ETP CH1360612134 -47.13%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 312.02%
21Shares Sui Staking ETP CH1360612159 259.12%
21Shares Stellar ETP CH1109575535 214.02%
21Shares Aave ETP CH1135202120 147.24%
21Shares Stacks Staking ETP CH1258969042 145.10%
21Shares Algorand ETP CH1146882316 137.07%
21Shares Injective Staking ETP CH1360612134 -22.18%
21Shares Immutable ETP CH1360612142 -34.81%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 343.32%
21Shares Stellar ETP CH1109575535 177.66%
21Shares Aave ETP CH1135202120 165.25%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 155.01%
21Shares Binance BNB ETP CH0496454155 99.39%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 863.36%
21Shares Ripple XRP ETP CH0454664043 502.68%
21Shares Bitcoin Core ETP CH1199067674 340.60%
21Shares Bitcoin ETP CH0454664001 329.45%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 308.42%

Fundamentaldaten

Valor 130137593
ISIN LU2674532929
Emittent T. Rowe Price Management
Aufgelegt in Luxembourg
Auflagedatum 04.10.2023
Kategorie Branchen: Gesundheitswesen
Währung GBP
Volumen 235’782’068.69
Depotbank J.P. Morgan SE, Luxembourg Branch
Geschäftsjahresende 31.12.
Berichtsstand 10.02.2025

Anlagepolitik

So investiert der Select Investment Series III SICAV - T. Rowe Price Health Sciences Equity Fund Qd Fonds: To increase the value of its shares, over the long term, through growth in the value of, and income from, its investments. The fund is actively managed and invests mainly in a diversified portfolio of shares of companies that are involved in the research, development, production, or distribution of products or services related to health sciences. The companies may be anywhere in the world, including emerging markets, with a focus on companies in the United States.

ETP Performance: Select Investment Series III SICAV - T. Rowe Price Health Sciences Equity Fund Qd Fonds

Performance 1 Jahr
0.97
Performance 2 Jahre -
Performance 3 Jahre -
Performance 5 Jahre -
Performance 10 Jahre -